Latest Articles

Publication Date
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug By Investing.com - Investing.com Australia

Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug By Investing.com Investing.com Australia

Published: Sept. 26, 2025, 11:03 a.m.
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug By Investing.com - Investing.com South Africa

Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug By Investing.com Investing.com South Africa

Published: Sept. 26, 2025, 10:56 a.m.
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug - Investing.com India

Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug Investing.com India

Published: Sept. 26, 2025, 10:48 a.m.
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug - Investing.com

Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug Investing.com

Published: Sept. 26, 2025, 10:25 a.m.
Deep infiltrating endometriosis: retroperitoneal endometriosis-a case report - BMC Women's Health

Deep infiltrating endometriosis: retroperitoneal endometriosis-a case report BMC Women's Health

Published: Sept. 26, 2025, 10:06 a.m.
From gut to gamete: how the microbiome influences fertility and preconception health - BioMed Central

From gut to gamete: how the microbiome influences fertility and preconception health BioMed Central

Published: Sept. 26, 2025, 7:05 a.m.
Dual Targeting of Orphan Nuclear Receptors NR4A1 and NR4A2 for Non-Hormonal Endometriosis Therapy.

Previous studies show that orphan nuclear receptor 4A1 (NR4A1) regulated endometriotic cell growth, survival, estrogen receptor β (ERβ), mTOR signaling and fibrosis. NR4A2 is also expressed in epithelial and stromal …

Published: Sept. 26, 2025, midnight
Endometriosis Diagnostic Delay and Its Correlates: Results from the ComPaRe-Endometriosis Cohort.

Background: An average time to diagnosis of 7 years is commonly described for endometriosis; diagnostic delay for adenomyosis is unknown. This cross-sectional study aimed to describe diagnostic delay for endometriosis …

Published: Sept. 26, 2025, midnight
FIGO committee opinion: Environmental drivers of gynecologic and reproductive health.

This FIGO committee opinion paper addresses the growing body of evidence linking environmental exposures to common gynecologic and reproductive conditions across the life course. From adolescence through menopause, women are …

Published: Sept. 26, 2025, midnight
Endometriosis in para-aortic lymph nodes without any pelvic endometriosis: the first case report, sequencing analysis and literature review.

Published: Sept. 26, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!